CI vs PRLD · P/E 2.4, rev $274.90B vs rev $6.5M
Cigna Corp (CI) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the CI and PRLD stock pages for the full models.
Not investment advice.